Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by Actavis Pharma, Inc., priced at $0.0960 per EA under NDC 00591042401. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591042401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA073449On Market Since
9/23/1993
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 42.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0960 per EA |
|---|---|
| All-time high | $0.1760 (Feb 12, 2014) |
| All-time low | $0.0721 (Nov 20, 2024) |
| 52-week high | $0.0983 |
| 52-week low | $0.0915 |
| Median price | $0.1089 |
| Average price | $0.1164 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by Actavis Pharma, Inc., is $0.0960 per EA (NDC 00591042401), effective Jun 24, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 42.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Since Nov 28, 2013, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0721 (Nov 20, 2024) to a high of $0.1760 (Feb 12, 2014), with a median of $0.1089 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
7 NADAC-published products share the same active ingredient, strength, and dosage form as TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, but none are currently priced below it.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 00591042401) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification